- Home
- MHUA vs MIRA Comparison
MHUA vs MIRA Comparison
Compare MHUA & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHUA
- MIRA
- Stock Information
- Founded
- MHUA 1990
- MIRA 2020
- Country
- MHUA China
- MIRA United States
- Employees
- MHUA N/A
- MIRA N/A
- Industry
- MHUA Medical Specialities
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- MHUA Health Care
- MIRA Health Care
- Exchange
- MHUA Nasdaq
- MIRA Nasdaq
- Market Cap
- MHUA 9.6M
- MIRA 17.4M
- IPO Year
- MHUA 2022
- MIRA 2023
- Fundamental
- Price
- MHUA $0.32
- MIRA $1.12
- Analyst Decision
- MHUA
- MIRA Strong Buy
- Analyst Count
- MHUA 0
- MIRA 2
- Target Price
- MHUA N/A
- MIRA $14.00
- AVG Volume (30 Days)
- MHUA 308.0K
- MIRA 334.0K
- Earning Date
- MHUA 09-20-2024
- MIRA 11-12-2024
- Dividend Yield
- MHUA N/A
- MIRA N/A
- EPS Growth
- MHUA 29.93
- MIRA N/A
- EPS
- MHUA 0.37
- MIRA N/A
- Revenue
- MHUA $94,252,537.00
- MIRA N/A
- Revenue This Year
- MHUA N/A
- MIRA N/A
- Revenue Next Year
- MHUA N/A
- MIRA N/A
- P/E Ratio
- MHUA $0.87
- MIRA N/A
- Revenue Growth
- MHUA N/A
- MIRA N/A
- 52 Week Low
- MHUA $0.25
- MIRA $0.51
- 52 Week High
- MHUA $1.47
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- MHUA 41.66
- MIRA 45.90
- Support Level
- MHUA $0.30
- MIRA $1.10
- Resistance Level
- MHUA $0.33
- MIRA $1.33
- Average True Range (ATR)
- MHUA 0.03
- MIRA 0.07
- MACD
- MHUA 0.01
- MIRA -0.00
- Stochastic Oscillator
- MHUA 50.00
- MIRA 17.35
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.